| Total, N (%) | 137 (100.0) | 37 (27.0) | 23 (16.8) | 29 (21.1) | 44 (32.1) | 4 (2.9) |
| FIGO 2014 stage | | | | | | |
| Stage 1 | 86 (62.3) | 24 (64.9) | 13 (56.5) | 10 (34.5) | 39 (88.6) | 0 (0.0) |
| Stage 2 | 11 (8.0) | 2 (5.4) | 2 (8.7) | 6 (20.7) | 0 (0.0) | 1 (25.0) |
| Stage 3 | 23 (16.7) | 6 (16.2) | 7 (30.4) | 7 (24.1) | 1 (2.3) | 2 (50.0) |
| Stage 4 | 15 (10.9) | 4 (10.8) | 1 (4.3) | 6 (20.7) | 3 (6.8) | 1 (25.0) |
| Age | | | | | | |
| Median (IQR) | 23 (14) | 21 (10) | 27 (13) | 23 (14) | 26 (15.5) | 23 (11.75) |
| < 18, N (%) | 31 (22.6) | 10 (27.0) | 3 (13.0) | 3 (10.3) | 14 (31.8) | 1 (25.0) |
| > 18, N (%) | 106 (77.3) | 27 (73.0) | 20 (87.0) | 26 (89.7) | 30 (68.2) | 3 (75.0) |
| Surgical route | | | | | | |
| Laparotomy | 109 (80.0) | 23 (62.1) | 21 (91.3) | 25 (86.2) | 36 (81.8) | 4 (100.0) |
| Laparoscopy | 22 (16.0) | 11 (8.0) | 2 (8.7) | 2 (6.9) | 7 (5.1) | 0 (0.0) |
| Surgery type | | | | | | |
| Fertility sparing | 120 (87.6) | 31 (83.8) | 22 (95.7) | 24 (82.8) | 40 (90.9) | 3 (75.0) |
| Non-fertility sparing | 16 (11.7) | 6 (16.2) | 1 (8.7) | 4 (13.8) | 4 (9.1) | 1 (25.0) |
| Primary debulking | 10 | 1 | 1 | 4 | 1 | 1 |
| Interval debulking | 5 | 2 | 0 | 0 | 3 | 0 |
| Prophylactic surgery | 3 | 3 | 0 | 0 | 0 | 0 |
| Chemotherapy | | | | | | |
| None | 61 (44.5) | 15 (40.5) | 4 (17.4) | 9 (31.0) | 33 (75.0) | 0 (0.0) |
| Neoadjuvant | 16 (11.7) | 7 (18.9) | 2 (8.7) | 2 (6.9) | 4 (9.1) | 1 (25.0) |
| Adjuvant | 60 (43.8) | 15 (40.5) | 17 (73.9) | 18 (62.1) | 7 (15.9) | 3 (75.0) |
| Residual disease | | | | | | |
| none | 112 (81.8) | 35 (94.6) | 14 (60.9) | 21 (72.4) | 39 (88.6) | 3 (75.0) |
| <1cm | 4 (2.9) | 0 (0.0) | 2 (8.7) | 1 (3.4) | 1 (2.3) | 0 (0.0) |
| >1cm | 20 (14.6) | 2 (5.4) | 7 (30.4) | 6 (20.7) | 4 (9.1) | 1 (25.0) |
| Completion surgery | | | | | | |
| performed | 11 (8.0) | 1 (2.7) | 4 (17.4) | 2 (6.9) | 4 (9.1) | 0 (0.0) |
| not performed | 124 (90.5) | 36 (97.3) | 19 (82.6) | 26 (89.7) | 39 (88.6) | 4 (100.0) |
| Recurrence | 39 (28.5) | 3 (8.1) | 8 (34.8) | 15 (51.7) | 9 (20.5) | 4 (100.0) |
| Time to recurrence (days) | | | | | | |
| median (IQR) | 211 (249) | 363 (1398.5) | 153 (296.25) | 174 (126.5) | 212 (208) | 367.5 (368.75) |
| Censor outcome | | | | | | |
| Dead | 10 (7.3) | 0 (0.0) | 3 (13.0) | 5 (17.2) | 0 (0.0) | 2 (50.0) |
| Alive with disease | 3 (2.2) | 0 (0.0) | 1 (0.0) | 0 (0.0) | 1 (2.2) | 1 (25.0) |
| Alive and disease free | 127 (17.5) | 37 (100.0) | 20 (87.0) | 24 (82.8) | 43 (97.7) | 1 (25.0) |
| Time to censor outcome (years) | | | | | | |
| median (IQR) | 4.6 (4.6) | 6.0 (3.2) | 4.9 (4.6) | 4.9 (5.2) | 3.2 (3.4) | 1.3 (1.6) |